Kevin Church Athira Pharma, Inc. (ATHA) insider trading activity
Kevin Church is CHIEF SCIENTIFIC OFFICER of Athira Pharma, Inc.. Currently has a direct ownership of 20,681 shares of ATHA, which is worth approximately $95,339. The most recent transaction as insider was on Jun 08, 2021, when has been sold 3,152 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $3,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
20.7K
87.76%
3M change
84.18%
12M change
Total Value Held
$95,339
KC
Kevin Church
CHIEF SCIENTIFIC OFFICER
Bothell, WA